Ebastine transfer factor treatment of chronic oral Urticaria.docVIP

 PAGE \* MERGEFORMAT 6 Ebastine transfer factor treatment of chronic oral Urticaria Of: Tan Jing Li Haixia Zhao Xiao-Hong Sun [Abstract] Objective: To observe the ebastine, transfer factor oral efficacy of the treatment of chronic urticaria. METHODS: A randomized controlled by oral ebastine, oral transfer factor for the observation group, with oral chlorpheniramine as the control group were compared. Results: The observation group was 90.0%, control group was 43.3%, the difference was statistically significant (P lt;0.005. Conclusion: ebastine, oral transfer factor treatment of chronic urticaria Measles efficacy, rapid onset, safe and reliable, is an effective method in treating chronic urticaria. [Keywords:] ebastine, oral transfer factor in chronic urticaria Most chronic urticaria of unknown etiology, longer duration, treatment, skin problems, seriously affecting the quality of life of patients .2006 June to December 2007 the author with ebastine, transfer factor oral liquid treatment for 30 patients with chronic urticaria measles patients, a significant effect, are as follows. 1 Subjects and methods 1.1 Object 60 cases were all patients in our hospital, duration of 3 months to 5 years, with an average 158 days. Randomly divided into two groups 30 patients in the observation group 21 males and 9 females, aged 21 to 65 years, mean age of 43 years, control group 17 males and 13 females, aged 20 to 58 years, mean age 39 years. two groups of age, sex, condition and other similar, the difference was not statistically significant (Pgt; 0.05, comparable. treatment 1 week before the two groups of patients were not taking other antihistamines and corticosteroids with 60 patients, liver and kidney functions were normal. Observed treatment group was treated with 1.2 ebastine (Hangzhou Ling Medicare Australia Pharmaceutical Co 10mg / day oral oral transfer factor (Changchun Extrawell Pharmaceutical 10mL / time, 2 times / day, control of oral chlorphe